Management of cancer-associated venous thromboembolism (VTE) is essential in treatment
selection and cancer prognosis. However, to date, there is no method to assess the risk of …

Background Patients with lung cancer are known to be at increased risk for venous
thromboembolism (VTE). Venous thromboembolism is associated with increased risk for …

According to the most recent data from the National Cancer Center, venous
thromboembolism (VTE) has unsurprisingly become one of the most common complications …

Epidemiology and risk factors for venous thromboembolism in... : Current Opinion in Oncology
Epidemiology and risk factors for venous thromboembolism in lung cancer : Current Opinion …

Introduction The risk of venous thromboembolism (VTE) varies among tumour types, and
different cancer type-specific risks for VTE prediction remain undefined. We aimed to …

Introduction This subanalysis aimed to provide real-world data on venous thromboembolism
(VTE) from patients with lung cancer in the Cancer-VTE Registry. Methods The primary …

Background Cancer-associated venous thromboembolism (VTE) is common in patients with
primary lung cancer. It has been understudied which authoritative risk assessment score of …

Background: Venous thromboembolism (VTE) is a potentially preventable cause of death in
people with lung cancer. Identification of those most at risk and high-risk periods may …

This study aimed to develop and validate a risk score for early prediction of venous
thromboembolism (VTE) in patients with lung cancer. A total of 827 patients with lung cancer …

Background Venous thromboembolism (VTE) is the well-known complication of cancer,
especially among lung cancer patients. The objective of this study is to identify the …